Memorial Sloan Kettering Cancer Center researchers have found RNA neoantigen vaccines that generate long-lived, functional ...

Vaccines to treat cancers have been around since 2010, the first being approved for prostate cancer, and another in 2015 for ...

Results from a trial of an mRNA vaccine for pancreatic cancer have shown that the vaccine reduces the chance of the cancer ...

As per a new study, the potential of mRNA vaccines offers a personalized treatment for patients with pancreatic cancer.

Pancreatic cancer is the 10th deadliest form of cancer in the United States, according to the National Cancer Institute.

A promising new mRNA-based vaccine for pancreatic cancer has shown potential in reducing the recurrence of the disease ...

Adding a personalized mRNA vaccine to standard treatment could offer new hope for pancreatic cancer patients, a small ...

Midlands man Daniel Mooney is fighting for his life against a rare and aggressive form of cancer. The 37-year-old was ...

Researchers at Yale University in a small, yet to be published study found that Covid vaccines were linked to a rare ...

A Memorial Sloan Kettering phase 1 clinical trial revealed an immune response in some pancreatic cancer patients. Study ...

The phase 1 trial results, published Feb. 19 in Nature, evaluated the personalized mRNA neoantigen vaccine autogene cevumeran in combination with surgery, immunotherapy drug atezolizumab and ...